INM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
INM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Short-Term Debt & Capital Lease Obligation is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt. InMed Pharmaceuticals's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.35 Mil.
Long-Term Debt & Capital Lease Obligation is the debt and capital lease obligation due more than 12 months in the future. InMed Pharmaceuticals's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.73 Mil.
The historical data trend for InMed Pharmaceuticals's Short-Term Debt & Capital Lease Obligation can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
InMed Pharmaceuticals Annual Data | |||||||||||||||||||||
Trend | Jun14 | Jun15 | Jun16 | Jun17 | Jun18 | Jun19 | Jun20 | Jun21 | Jun22 | Jun23 | |||||||||||
Short-Term Debt & Capital Lease Obligation | Get a 7-Day Free Trial | - | 0.07 | 0.08 | 0.40 | 0.38 |
InMed Pharmaceuticals Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Short-Term Debt & Capital Lease Obligation | Get a 7-Day Free Trial | 0.42 | 0.38 | 0.29 | 0.36 | 0.35 |
This is the portion of a company's debt and capital lease obligation that need to be paid within the next 12 months. It equals Short-Term Debt plus Short-Term Capital Lease Obligation. This gives investors an idea of how much money the company needs to pay down for the principle of its debt.
In the notes to balance sheet in annual (10-K) or quarterly (10-Q) reports, companies usually break down the details of the debt, their due dates, the interest rates etc.
Be Aware
Stay away from companies that roll over the debt e.g. Bear Stearns
When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.
His favorite Wells Fargo has 57 cents short term debt for every dollar of long term
Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term
Thank you for viewing the detailed overview of InMed Pharmaceuticals's Short-Term Debt & Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.
Jonathan Tegge | officer: Interim CFO | 217 W. MAIN STREET, SOMERVILLE NJ 08876 |
Sarah Li | officer: VP, Accounting and Controller | 310-815 WEST HASTINGS ST., VANCOUVER Z4 V6C1B4 |
Nicole Lemerond | director | 3 MURRAY HILL ROAD, SCARSDALE NY 10583 |
Bryan T Baldasare | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Eric A Adams | director, officer: President & CEO | C/O INMED PHARMACEUTICALS INC., SUITE 310 - 815 HASTINGS STREET, VANCOUVER A1 V6C 1B4 |
Brenda Edwards | officer: Interim CFO | 111-1232 JOHNSON ST., COQUITLAM A1 V3B 4T2 |
Janet P Grove | director | 510 WEST GEORGIA STREET, SUITE 1800, VANCOUVER A1 V5T 4T5 |
Bruce Colwill | officer: CFO | C/O INMED PHARMACEUTICALS INC., SUITE 310 - 815 HASTINGS STREET, VANCOUVER A1 V6C 1B4 |
Shane Aaron Johnson | officer: SVP & GM of BayMedica LLC | 930 TAHOE BLVD., SUITE 802-433, INCLINE VILLAGE NV 89451 |
Adam D. Cutler | director | 9301 AMBERGLEN BOULEVARD, SUITE 100, C/O MOLECULAR TEMPLATES, INC., AUSTIN TX 78729 |
William J Garner | director | 875 MAHLER ROAD, SUITE 235, BURLINGAME CA 94010 |
Catherine Sazdanoff | director | 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244 |
Eric C Hsu | officer: Sr. VP, Pre-Clinical Res/Dev | C/O INMED PHARMACEUTICALS INC., SUITE 310 - 815 HASTINGS STREET, VANCOUVER A1 V6C 1B4 |
Michael Woudenberg | officer: VP, Chem/Manufacturing/Control | C/O INMED PHARMACEUTICALS INC., SUITE 310 - 815 HASTINGS STREET, VANCOUVER A1 V6C 1B4 |
Mancini Alexandra Diane Janet | officer: Sr VP, Clinical Reg Affairs | C/O INMED PHARMACEUTICALS INC., SUITE 310 - 815 HASTINGS STREET, VANCOUVER A1 V6C 1B4 |
From GuruFocus
By PurpleRose PurpleRose • 08-23-2022
By Value_Insider Value_Insider • 12-16-2022
By GuruFocusNews GuruFocusNews • 07-02-2022
By Value_Insider Value_Insider • 11-16-2022
By sperokesalga sperokesalga • 02-10-2023
By PurpleRose PurpleRose • 07-12-2022
By GuruFocusNews GuruFocusNews • 07-04-2022
By GuruFocusNews GuruFocusNews • 07-07-2022
By Value_Insider Value_Insider • 11-21-2022
By PurpleRose PurpleRose • 07-25-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.